clinical trial · NCT06396039
A Study to Assess the Effectiveness and Safety of Ozanimod in Chinese Adults With Relapsing Multiple Sclerosis
Bristol-Myers Squibb·phase4·active not recruiting·n = 84
Relapsing Multiple SclerosisBMS-986374
brief summary
The purpose of this study is to assess the effectiveness and safety of ozanimod in Chinese adults with relapsing multiple sclerosis.
started
May 15, 2024
primary completion
Dec 29, 2028
completion
Mar 30, 2029
last updated
Apr 16, 2025
official title
A Phase 4, Multicenter, Single-arm, Open-label Study to Evaluate the Effectiveness and Safety of Oral Ozanimod for Relapsing Multiple Sclerosis (RMS) in Chinese Participants
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol